Ocumetics Technology Corp. (OTCFF)
USD 0.2
(0.0%)
USD 0.2
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.03 Million CAD | -24.56% |
| 2022 | 1.37 Million CAD | 66.48% |
| 2021 | 825.25 Thousand CAD | 266.26% |
| 2020 | 225.32 Thousand CAD | -13.95% |
| 2019 | 261.84 Thousand CAD | -13.12% |
| 2018 | 301.37 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 947.39 Thousand CAD | -8.59% |
| 2023 FY | 1.03 Million CAD | -24.56% |
| 2023 Q4 | 1.03 Million CAD | -20.54% |
| 2023 Q3 | 1.3 Million CAD | 37.29% |
| 2023 Q1 | 1.51 Million CAD | 10.21% |
| 2023 Q2 | 950.1 Thousand CAD | -37.25% |
| 2022 Q3 | 1.78 Million CAD | -9.4% |
| 2022 Q2 | 1.97 Million CAD | -13.05% |
| 2022 Q1 | 2.26 Million CAD | -14.55% |
| 2022 Q4 | 1.37 Million CAD | -23.11% |
| 2022 FY | 1.37 Million CAD | 66.48% |
| 2021 Q4 | 2.65 Million CAD | -7.76% |
| 2021 FY | 825.25 Thousand CAD | 266.26% |
| 2021 Q3 | 2.87 Million CAD | 1620.32% |
| 2021 Q1 | 210.45 Thousand CAD | -6.6% |
| 2021 Q2 | 167.24 Thousand CAD | -20.53% |
| 2020 Q3 | - CAD | -100.0% |
| 2020 Q4 | 225.32 Thousand CAD | 0.0% |
| 2020 Q2 | 582.58 Thousand CAD | 0.0% |
| 2020 FY | 225.32 Thousand CAD | -13.95% |
| 2019 FY | 261.84 Thousand CAD | -13.12% |
| 2018 FY | 301.37 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | 43.613% |
| Ansell Limited | 3.23 Billion USD | 99.968% |
| Ansell Limited | 3.24 Billion USD | 99.968% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | 99.788% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -245.061% |
| Psykey, Inc. | 1.72 Million USD | 39.999% |
| ConvaTec Group Plc | 3.7 Billion USD | 99.972% |
| ConvaTec Group Plc | 3.71 Billion USD | 99.972% |
| Encision Inc. | 3.81 Million USD | 72.802% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -58.991% |
| LifePoint, Inc. | 8.8 Million USD | 88.235% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 93.504% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -15.802% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | 81.118% |
| Reflect Scientific, Inc. | 2.66 Million USD | 61.166% |
| SmileDirectClub, Inc. | 597.06 Million USD | 99.826% |
| Sector 10, Inc. | 1000.00 USD | -103543.2% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.978% |
| SheerVision, Inc. | 837.56 Thousand USD | -23.743% |
| United Health Products, Inc. | 284.64 Thousand USD | -264.116% |
| Vasamed, Inc. | 1.6 Million USD | 35.233% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -364.407% |
| Yubo International Biotech Limited | 2.34 Million USD | 55.869% |